Cupric Chloride

CHEMBL444436 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
134.4 g/mol
LogP
Phase
4

An inorganic copper salt used as a trace element supplement in parenteral nutrition to prevent copper deficiency. Copper is essential for numerous enzymatic processes in the body including iron metabolism and connective tissue formation.

Peso molecular

134,4500 g/mol

TPSA

0,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl[Cu]Cl

InChI

InChI=1S/2ClH.Cu/h2*1H;/q;;+2/p-2

Molecular Formula

Cl2Cu

HBD / HBA

- / -

Enlaces Rotables

0

Átomos Pesados

3

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

An inorganic copper salt used as a trace element supplement in parenteral nutrition to prevent copper deficiency. Copper is essential for numerous enzymatic processes in the body including iron metabolism and connective tissue formation.

Yes, Cupric Chloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL444436. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 24014. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.